Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7de02e4b28736bfb52de8bb358be203e |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-07 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-07 |
filingDate |
2022-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75161f2ffb6829c128105ae076c8c76c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17075ba483d70ea858fa668cac9b743f |
publicationDate |
2022-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2022150840-A1 |
titleOfInvention |
Psilocybin and norbaeocystin compositions and methods of treatment |
abstract |
Provided is a pharmaceutical composition comprising two or more tryptamines that are present in Psilocybe magic mushrooms. Provided is a pharmaceutical composition comprising heterologously produced psilocybin and heterologously produced norbaeocystin. Also provided is a method of treating a neurological or psychological disorder or condition in a patient, comprising administering to the patient an effective amount of a pharmaceutical composition comprising psilocybin and an effective amount of a pharmaceutical composition comprising norbaeocystin. Also provided is a method of treating a neurological or psychological disorder or condition in a patient, comprising administering to the patient an effective amount of a pharmaceutical composition comprising psilocybin and an effective amount of a pharmaceutical composition comprising norbaeocystin. In some embodiments, the psilocybin is heterologously produced. In some embodiments, the norbaeocystin is heterologously produced. |
priorityDate |
2021-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |